Original Research
Accepted on 28 Aug 2025
Safety assessment of Gemtuzumab ozogamicin: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
in Translational Medicine
Original Research
Accepted on 28 Aug 2025
in Translational Medicine
Original Research
Accepted on 28 Aug 2025
in Addictive Disorders
Original Research
Accepted on 28 Aug 2025
in Environmental Informatics and Remote Sensing
Review
Accepted on 28 Aug 2025
in Obesity
Original Research
Accepted on 28 Aug 2025
in Environmental Economics and Management
Original Research
Accepted on 28 Aug 2025
in Reproduction
Systematic Review
Accepted on 28 Aug 2025
in Environmental Informatics and Remote Sensing
Systematic Review
Accepted on 28 Aug 2025
in Translational and Clinical Endocrinology
Review
Accepted on 28 Aug 2025
in Neurocognitive Aging and Behavior
Original Research
Accepted on 28 Aug 2025
in Intensive Care Cardiovascular Medicine
Original Research
Accepted on 28 Aug 2025
in Ethnopharmacology
Original Research
Accepted on 28 Aug 2025
in Cardiovascular Epidemiology and Prevention
Review
Accepted on 28 Aug 2025
in Access and Barriers to Reproductive Health Services
Original Research
Accepted on 28 Aug 2025
in Access and Barriers to Reproductive Health Services
Original Research
Accepted on 28 Aug 2025
in Nutrition and Metabolism
Original Research
Accepted on 28 Aug 2025
in Functional Plant Ecology